Cytori Cell Research Institute, The Current Fiscal Year Net Income Revised Downward to a Loss, 37% Deficit Against Net Assets, Decides to Continue No Dividend Policy

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 14, 2025 4:00 pm JST Earnings

3750 ADR120S,Inc. 【J-GAAP】

Earnings Report

Cytori Cell Research Institute,Inc. <3750> [TSE Std] announced its financial results after the market closed on February 14th (16:00). The consolidated net loss for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded to a loss of 0.75 billion yen (compared to a loss of 0.55 billion yen in the same period last year).

In addition, the full-year consolidated net income/loss has been revised downward from an expected profit of 0.1 billion yen to a loss of 1.03 billion yen (compared to a profit of 0.13 billion yen in the previous period), turning to a loss outlook The deficit amounted to a 37.0% impairment of net assets at the end of the previous fiscal year..

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated net income/loss for the October to March period (2H) has been revised downward from an expected profit of 0.53 billion yen to a loss of 0.6 billion yen (compared to a profit of 0.58 billion yen in the same period of the previous year), turning to a loss outlook.

At the same time, the company has decided to forego the year-end lump-sum dividend for the current fiscal year, which had previously been undecided (compared to no dividend in the prior term), and the policy has been set to continue with no dividends.

In the most recent three-month period, from October to December (3Q), the consolidated net loss expanded to a loss of 0.31 billion yen (compared to a loss of 0.1 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -25.5% in the same period last year to -812.5%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	1,651	-515	-601	-722	-81.0	ー	Feb 10, 2023	J-GAAP
Apr - Dec, 2023	1,411	-494	-595	-552	-61.9	ー	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	115	-602	-636	-751	-84.2	ー	Feb 14, 2025	J-GAAP
YoY	-91.8%	-21.9%	-6.9%	-36.1%	-36.0%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	1,193	323	332	535	59.9	－	Nov 14, 2024	J-GAAP
Oct - Mar, 2024 New	34	-454	-498	-601	-67.3	0	Feb 14, 2025	J-GAAP
Revision Rate	-97.2%	－	－	－	－

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	1,284	-84	-87	103	11.5	－	May 14, 2024	J-GAAP
Mar, 2025 New	125	-861	-917	-1,033	-115.7	0	Feb 14, 2025	J-GAAP
Revision Rate	-90.3%	-925.0%	-954.0%	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	698	-418	-483	581	65.1	0	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	34	-454	-498	-601	-67.3	0	Feb 14, 2025	J-GAAP
YoY	-95.1%	-8.6%	-3.1%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,144	-794	-862	-1,059	-118.7	0	May 12, 2023	J-GAAP
Mar, 2024	1,560	-772	-906	138	15.5	0	May 14, 2024	J-GAAP
Mar, 2025 Guidance	125	-861	-917	-1,033	-115.7	0	Feb 14, 2025	J-GAAP
YoY	-92.0%	-11.5%	-1.2%	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	549	-140	-172	-109	-12.2	-25.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	149	-278	-311	690	77.4	-186.6	May 14, 2024	J-GAAP
Apr - Jun, 2024	39	-239	-233	-242	-27.2	-612.8	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	52	-168	-186	-190	-21.3	-323.1	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	24	-195	-217	-319	-35.8	-812.5	Feb 14, 2025	J-GAAP
YoY	-95.6%	-39.3%	-26.2%	-192.7%	-192.6%